GlobeNewsWire
04 Sept 2026, 17:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
The FTC, California, and Utah have sued Hims & Hers for allegedly deceptive billing practices and misleading consumers about medical consultations. — Regulatory action regarding core business practices often leads to significant fines and forced changes to revenue models.
-0.60The FTC alleges Hims & Hers shared private consumer health information with third-party platforms including Meta and Snap. — Privacy breaches involving health data carry high reputational risk and potential for severe regulatory penalties.
-0.50A class action securities lawsuit has been filed against Hims & Hers on behalf of investors who suffered losses between August 2025 and July 2026. — While common following a stock drop, securities litigation creates long-term legal overhang and potential settlement costs.
-0.30Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is facing a class action lawsuit and an FTC suit alleging deceptive billing and privacy violations.
Mentioned as a third party that received consumer health information in violation of privacy expectations.
Mentioned as a third party that received consumer health information in violation of privacy expectations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
1h ago
